These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 15150380)

  • 1. Risk factors for community-acquired ciprofloxacin-resistant Escherichia coli urinary tract infection.
    Killgore KM; March KL; Guglielmo BJ
    Ann Pharmacother; 2004; 38(7-8):1148-52. PubMed ID: 15150380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors for ciprofloxacin resistance among Escherichia coli strains isolated from community-acquired urinary tract infections in Turkey.
    Arslan H; Azap OK; Ergönül O; Timurkaynak F;
    J Antimicrob Chemother; 2005 Nov; 56(5):914-8. PubMed ID: 16174685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Temporal changes in the prevalence of community-acquired antimicrobial-resistant urinary tract infection affected by Escherichia coli clonal group composition.
    Smith SP; Manges AR; Riley LW
    Clin Infect Dis; 2008 Mar; 46(5):689-95. PubMed ID: 18230040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors for community-acquired urinary tract infection due to quinolone-resistant E. coli.
    Colodner R; Kometiani I; Chazan B; Raz R
    Infection; 2008 Feb; 36(1):41-5. PubMed ID: 18193386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors for fluoroquinolone-resistant Escherichia coli in adults with community-onset febrile urinary tract infection.
    van der Starre WE; van Nieuwkoop C; Paltansing S; van't Wout JW; Groeneveld GH; Becker MJ; Koster T; Wattel-Louis GH; Delfos NM; Ablij HC; Leyten EM; Blom JW; van Dissel JT
    J Antimicrob Chemother; 2011 Mar; 66(3):650-6. PubMed ID: 21123286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors for community-onset urinary tract infections due to Escherichia coli harbouring extended-spectrum beta-lactamases.
    Calbo E; Romaní V; Xercavins M; Gómez L; Vidal CG; Quintana S; Vila J; Garau J
    J Antimicrob Chemother; 2006 Apr; 57(4):780-3. PubMed ID: 16492721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Community infections caused by extended-spectrum beta-lactamase-producing Escherichia coli.
    Rodríguez-Baño J; Alcalá JC; Cisneros JM; Grill F; Oliver A; Horcajada JP; Tórtola T; Mirelis B; Navarro G; Cuenca M; Esteve M; Peña C; Llanos AC; Cantón R; Pascual A
    Arch Intern Med; 2008 Sep; 168(17):1897-902. PubMed ID: 18809817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resistance to fluoroquinolones and treatment failure/short-term relapse of community-acquired urinary tract infections caused by Escherichia coli.
    Gagliotti C; Buttazzi R; Sforza S; Moro ML;
    J Infect; 2008 Sep; 57(3):179-84. PubMed ID: 18707763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dissemination of ST131 and ST393 community-onset, ciprofloxacin-resistant Escherichia coli clones causing urinary tract infections in Korea.
    Lee MY; Choi HJ; Choi JY; Song M; Song Y; Kim SW; Chang HH; Jung SI; Kim YS; Ki HK; Son JS; Kwon KT; Heo ST; Yeom JS; Shin SY; Chung DR; Peck KR; Song JH; Ko KS
    J Infect; 2010 Feb; 60(2):146-53. PubMed ID: 19932131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increasing antimicrobial resistance in Escherichia coli isolates from community-acquired urinary tract infections during 1998-2003 in Manisa, Turkey.
    Kurutepe S; Surucuoglu S; Sezgin C; Gazi H; Gulay M; Ozbakkaloglu B
    Jpn J Infect Dis; 2005 Jun; 58(3):159-61. PubMed ID: 15973007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimicrobial resistance in outpatient Escherichia coli urinary isolates in Dakar, Senegal.
    Sire JM; Nabeth P; Perrier-Gros-Claude JD; Bahsoun I; Siby T; Macondo EA; Gaye-Diallo A; Guyomard S; Seck A; Breurec S; Garin B
    J Infect Dev Ctries; 2007 Dec; 1(3):263-8. PubMed ID: 19734603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emergence of fluoroquinolone resistance in outpatient urinary Escherichia coli isolates.
    Johnson L; Sabel A; Burman WJ; Everhart RM; Rome M; MacKenzie TD; Rozwadowski J; Mehler PS; Price CS
    Am J Med; 2008 Oct; 121(10):876-84. PubMed ID: 18823859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Susceptibility of antimicrobial-resistant urinary Escherichia coli isolates to fluoroquinolones and nitrofurantoin.
    Karlowsky JA; Thornsberry C; Jones ME; Sahm DF
    Clin Infect Dis; 2003 Jan; 36(2):183-7. PubMed ID: 12522750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nitrofurantoin: the return of an old friend in the wake of growing resistance.
    Kashanian J; Hakimian P; Blute M; Wong J; Khanna H; Wise G; Shabsigh R
    BJU Int; 2008 Dec; 102(11):1634-7. PubMed ID: 18657135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trimethoprim/sulfamethoxazole resistance in urinary tract infections.
    Guneysel O; Onur O; Erdede M; Denizbasi A
    J Emerg Med; 2009 May; 36(4):338-41. PubMed ID: 18325714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibiotic resistance of Escherichia coli from community-acquired urinary tract infections in relation to demographic and clinical data.
    Alós JI; Serrano MG; Gómez-Garcés JL; Perianes J
    Clin Microbiol Infect; 2005 Mar; 11(3):199-203. PubMed ID: 15715717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [E. coli: resistance to quinolones and beta-lactams of clinical strains isolated in the Franche-Comté region of France].
    Talon D; Lallemand-De-Conto S; Thouverez M; Bertrand X
    Pathol Biol (Paris); 2004 Mar; 52(2):76-81. PubMed ID: 15001235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for antibiotic-resistant Escherichia coli isolated from hospitalized patients with urinary tract infections: a prospective study.
    Sotto A; De Boever CM; Fabbro-Peray P; Gouby A; Sirot D; Jourdan J
    J Clin Microbiol; 2001 Feb; 39(2):438-44. PubMed ID: 11158087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Antibiotic resistance among E. coli isolates from urinary tract infections (1999-2000): a multicenter study].
    Smaoui H; Mahjoubi F; Boutiba I; Jouaihia W; Thabet L; Znazen A; Kammoun A; Mezghanni S; Triki O; Hammami A; Ben Hassen A; Kechrid A; Ben Redjeb S
    Tunis Med; 2003 Jun; 81(6):390-4. PubMed ID: 14534944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Escherichia coli from community-acquired urinary tract infections resistant to fluoroquinolones and extended-spectrum beta-lactams.
    Kariuki S; Revathi G; Corkill J; Kiiru J; Mwituria J; Mirza N; Hart CA
    J Infect Dev Ctries; 2007 Dec; 1(3):257-62. PubMed ID: 19734602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.